ArticleNaunyn-Schmiedeberg's archives of pharmacology2004
Nitric oxide (NO) is not involved in accentuated antagonism for chronotropy in the isolated mouse atrium.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 4 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nitric oxide (NO) is reportedly involved in accentuated antagonism in the canine blood-perfused sinoatrial (SA) node, and is thought to modulate cholinergic control of heart rate in rabbits. In the present study, we evaluated the involvement of NO in accentuated antagonism in an isolated preparation of both atria from C57BL/6J mice. Isoprenaline (10(-10) M-10(-7) M) had positive chronotropic effects but decreased rather than increased contraction strength. Carbachol (10(-8) M-3x10(-6) M) had a concentration-dependent, negative chronotropic action. In the presence of a submaximal concentration of isoprenaline (30 nM), the same concentration range of carbachol elicited a larger decrease in heart rate than in the absence of isoprenaline. The larger decrease in heart rate (accentuated antagonism) was not modified by the presence of the NO synthase inhibitor N(omega)-nitro-L-arginine methylester (L-NAME). Similar results were obtained using ICR strain mice. Isoprenaline increased cAMP content but not cGMP; carbachol in the presence of isoprenaline increased cGMP but had no further effects on cAMP. In the presence of L-NAME, the increase in cGMP elicited by carbachol was attenuated. In the isolated mouse atria, it appears that NO is not involved in accentuated antagonism due to lack of coupling between cGMP signalling and chronotropic function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.